DETECTION OF HUMAN-PAPILLOMAVIRUS-16 TRANSCRIPTIONAL ACTIVITY IN CERVICAL INTRAEPITHELIAL NEOPLASIA GRADE-III LESIONS AND CERVICAL CARCINOMAS BY NESTED REVERSE TRANSCRIPTION-POLYMERASE CHAIN-REACTION AND IN SITE HYBRIDIZATION
Hc. Selinka et al., DETECTION OF HUMAN-PAPILLOMAVIRUS-16 TRANSCRIPTIONAL ACTIVITY IN CERVICAL INTRAEPITHELIAL NEOPLASIA GRADE-III LESIONS AND CERVICAL CARCINOMAS BY NESTED REVERSE TRANSCRIPTION-POLYMERASE CHAIN-REACTION AND IN SITE HYBRIDIZATION, Laboratory investigation, 78(1), 1998, pp. 9-18
Continued expression of the oncogenes E6 and E7 of human papilloma vir
us ''high risk'' type 16 (HPV16) initiates neoplastic transformation a
nd maintenance of the malignant phenotype in cervical carcinoma cells.
The transcriptional activity of the HPV16 E6/E7 oncogenes was investi
gated in HPV16-containing cervical cell lines, cervical carcinomas, ac
id cervical intraepithelial neoplasia grade III lesions using the tech
niques of reverse transcription-polymerase chain reaction (RT-PCR), So
uthern blotting, and in situ hybridization. To facilitate detection of
the full-length HPV16 E6/E7 oncogene transcript and its characteristi
c splice products E6I and E6*II in cervical tissues, a nested RT-PCR
(nRT-PCR) assay was designed. Specific detection of HPV E6/E7 oncogene
transcripts in clinical specimens was found to be improved by nRT-PCR
, being as sensitive as the combination of conventional RT-PCR and sub
sequent Southern blot hybridization. Regarding the progression of prem
alignant lesions to cervical cancer, detection of the HPV transcriptio
nal activity by nRT-PCR may provide additional information for risk ev
aluations. Moreover, improvements in the amplification of HPV oncogene
transcripts may also be advantageous for monitoring the activity of H
PV before and after transcript-targeted gene therapy of cervical cance
r.